Respinor AS
PrivateLast Round
Convertible Debt
Jul 21, 2022
Total Funding Raised
$6.99M
Company Overview
Respinor AS operates in Healthcare & Life Sciences and is based in Oslo. Its latest recorded funding round was a Convertible Debt round in July 2022.
Respinor AS is a medical technology company that develops non-invasive, ultrasound-based devices for continuous diaphragm monitoring in critically ill patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Respinor AS Comparables
Compare Respinor AS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stimdia Medical | 74% | |
| Liberate Medical | 72% | |
| Lungpacer Medical | 70% |
For institutional investors. Book with your work email.
Respinor AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jul 21, 2022 | ||||
| Private Placement | Jan 4, 2022 | ||||
| Grant | Dec 11, 2020 | ||||
| Grant | Apr 20, 2018 | ||||
| Grant | Dec 1, 2016 | ||||
Seed | Sep 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Respinor AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inven2 | Seed |
| The Research Council of Norway | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 4, 2026
Monthly visitors increased 111% MoM, reaching 1.7K.
- Mar 27, 2025
Monthly visitors increased 78% MoM.
For institutional investors. Book with your work email.
Respinor AS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Respinor AS's valuation, stock price, and market status.
Is Respinor AS a public or private company?
Respinor AS is a private company.
What is the current stock price of Respinor AS?
Respinor AS is a private company, so its shares have no public market price. Caplight tracks Respinor AS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Respinor AS worth (valuation)?
Valuation information for Respinor AS is not publicly available.
Can I buy Respinor AS stock?
Respinor AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Respinor AS's last funding round?
Respinor AS's most recent funding round was Convertible Debt on July 21, 2022.
Who are the main investors in Respinor AS?
Key investors in Respinor AS include Inven2.
Will Respinor AS IPO soon?
No public IPO plans have been announced for Respinor AS.
How can I track Respinor AS secondary market activity?
Caplight tracks bids, offers, and trades in Respinor AS's shares on secondary markets.